Center for Biotechnology, NYS Center for Advanced Technology

CFB Director Clinton Rubin's research was just published in in JAMA-network: "Low magnitude mechanical signals, delivered using low intensity vibration, protects/builds the skeleton in young women fighting anorexia nervosa." Read more: https://lnkd.in/eP3nC76w The article was also the focus of an editorial from JAMA: https://lnkd.in/eJe7DqEj

Interested in SBIR/STTR Funding??Learn more with?NIH SEED?on 11/13. Hear about open funding opportunities, common application pitfalls and strategies for success.? Learn more and register here: https://lnkd.in/ejihuF8P

Upcoming Webinar: AI-Driven MedTech – Navigating the New Frontier Join MIDI Product Development on Wednesday, November 6th, at 12 PM ET for an exclusive live webinar hosted by AdvaMed where industry leaders will share insights into the transformative role of Artificial Intelligence (AI) in MedTech and healthcare. ?? Key Topics: - AI in Diagnostics and Treatment Planning: Real-world applications and future advancements - AI Automation in MedTech: From data analysis to clinical decision support - AI Integration in Healthcare Systems: Regulatory insights and practical considerations Presenters: Gregory Montalbano Principal at MIDI Medical Product Development Louisa Harvey Founder & Principal at ClariMed, Inc. Learn More & Register Here: https://lnkd.in/gNEpdc_4

Long Island Tapped for Nation-Leading Cell and Gene Therapy Innovation Hub: New York BioGenesis Park Governor Kathy Hochul has unveiled plans for New York BioGenesis Park, a groundbreaking $430 million Cell and Gene Therapy (CGT) Innovation Hub in Nassau County, Long Island. To be developed by The Albanese Organization, Inc., this state-of-the-art facility would catalyze CGT research, development, clinical manufacturing, and commercialization across New York State. With a historic $150 million state investment—the largest nationwide for a cell and gene therapy hub—NYBGP would accelerate the delivery of new therapies from lab to patient in New York’s diverse communities. This transformative hub aims to establish New York as the leading global destination for CGT innovation, driving economic growth, attracting top talent, and revolutionizing patient care statewide and beyond. The Center for Biotechnology is thrilled to be counted as a partner in this effort, and is looking forward to working with our colleagues in the initiative to help catalyze and accelerate life-changing therapies. New York BioGenesis Park is envisioned as a cutting-edge, full-service campus dedicated to advancing cell and gene therapies and accelerating their commercialization. At full build-out, the 700,000-square-foot park would create an end-to-end Cell and Gene Therapy innovation and supply center, featuring interconnected areas for public engagement, research, manufacturing, and collaboration. A cornerstone of New York BioGenesis Park is its incubator, supported by a $50 million investment from ESD’s Long Island Investment Fund. This facility will empower early-stage therapeutic developers by offering state-of-the-art wet lab space, shared equipment, office space, and other essential resources. This nurturing environment would provide Cell and Gene Therapy companies with access to specialized equipment, mentoring, and stage-appropriate financial guidance. As a critical component of New York BioGenesis Park, the incubator is poised to catalyze the growth of promising Cell and Gene Therapy companies by providing them with resources and support, unlocking their potential for innovation and success. Read the press release of Governor Hochul’s announcement here: https://lnkd.in/g6fgeeQU

Last week, at the 22nd Life Sciences Summit at the Alexandria Center, we brought together 55 thought leaders, 33 companies, and 300 attendees from the biopharma community to engage in dynamic discussions on trends in company building, regulations, funding, and partnership opportunities. The event sparked a vibrant, collaborative atmosphere, offering insights into the industry's evolving landscape and giving companies invaluable opportunities to connect with investors, forge new partnerships, and inform their go-to-market and fundraising strategies. Stay tuned for key takeaways in our Summit insights on the Center for Biotechnology blog. Thank you to our speakers and discussion leaders for facilitating engaging discussions and sharing diverse viewpoints during the plenary sessions. C-Suite Perspective: Raising Funds and Structuring Deals – Ben Kromnick, Matthew R. Kittay, Gerardo Ubaghs Carrión, J. Robert Coleman, Maria Luisa Pineda, PhD. Building Therapeutics for the New Decade: Precision Medicine vs. Mega-Blockbusters – Michael Baran, Troy André, Brian Busser, Gaurav Gupta, Nolan Townsend Fireside Chat: Creating Value in Early-Stage Drug Discovery: Dawn Bell, Lazar Boijic Next-Gen Advanced Therapies: Michael Norsen, Michael Aberman, Megan McGill, MD, PhD, Remo Moomiaie-Qajar M.D., Xinchen Wang Strategic Deal-Making: Shifting Dynamics: Dawn Bell, PharmD, Eva Chmielnicki, @Sanford Madigan, Marian Nakada, Ph.D., Rachel Mears The IRA’s Ripple Effect: Adrian Charbin, Ph.D. Ava Bousher, DVM, PharmD, Lawrence Monoson, Pete Vaccaro, Anton Xavier Next-Gen Bioconvergence Platform: Pavan Choksi, Orly Levitan, Isaac Stoner, Adam Yaari, Lazar Bojic Investor Roundtable: Jonathan Fassberg, Bridget Martell MA, MD, John Prufeta, Uciane Scarlett, Joel Sendek, Nimish Shah Thank you to our Sponsors: Stony Brook University Research: Kevin Gardner NIH Seed: Matt McMahon, Todd Rubenstein, Todd Haim University of Buffalo: Smitha James NYSTAR: Ben Verschueren Mercury: Ben Kromnick Withum: Alexander Dundara, CPA Fox Rothschild: Michael Glynn, Deborah Somerville, Matthew R. Kittay SVB: Anton Xavier Eisner Amper: Harold Hess, CPA, John Pennett Nixon Peabody: Karyn Bell, Allan Cohen A big thanks to the Center for Biotechnology team—Diane Fabel, Kate Hutchinson, Annette Depietri, Dee Dao, and Clint Rubin—for organizing another successful summit. Special recognition to our valued contributors, Julie Diamond and De-Ann Abraham, whose dedication made this event remarkable. Photos of event highlights below!

The Life Sciences Summit #LifeSci2024 is happening tomorrow! Oct 8-9 We’re excited to present: ? 8 Plenary Talks ? 35 Company Showcases ? 2 Social Receptions This event will bring together biopharma leaders, investors, and entrepreneurs to discuss key topics shaping the future of the industry, including: ? Building therapeutics for the next decade ? Next-gen platforms & advanced therapies ? The IRA’s impact on emerging biopharma strategies ? Positioning for Series A financing, IPOs, & partnerships as we approach 2025 We look forward to engaging discussions and valuable insights. Check out the event details in the image below.

The Life Sciences Summit #LifeSci2024 is happening tomorrow! Oct 8-9 We’re excited to present: ? 8 Plenary Talks ? 35 Company Showcases ? 2 Social Receptions This event will bring together biopharma leaders, investors, and entrepreneurs to discuss key topics shaping the future of the industry, including: ? Building therapeutics for the next decade ? Next-gen platforms & advanced therapies ? The IRA’s impact on emerging biopharma strategies ? Positioning for Series A financing, IPOs, & partnerships as we approach 2025 We look forward to engaging discussions and valuable insights. Check out the event details in the image below.

The LIMEP - Long Island Manufacturing Extension Partnership has a new Manufacturing Grant Opportunity for modernization and equipment needs.? Empire State Development (ESD) has a new grant opportunity to expand manufacturing businesses. Applications are due July 31st by 4PM for the ESD Manufacturing Grant program. Assisting small Long Island manufacturing companies is a top priority of ESD and the regional MEP. Those interested in applying are strongly encouraged to get in touch with the team at LIMEP: https://lnkd.in/e7pVnqjk Additional information about the Small Manufacturer Modernization Grant Program can be found on the ESD website: https://lnkd.in/gpqhP3e

Applied DNA Sciences Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing https://lnkd.in/ePuhM_m8

Career Opportunity: Scientist, Neuro at NILO Therapeutics (NY, NY) https://lnkd.in/ePqXdPg4